Medical research

FILE - In this Oct. 9, 2020 file photo, a health worker administers the first dose of a COVID-19 vaccine currently on phase III clinical trials to Cem Gun, an Emergency Medicine Physician, at the Acibadem Hospital in Istanbul, Friday, Oct. 9, 2020. Turkish health minister Fahrettin Koca, who had previously announced an agreement with Chinese biopharmaceutical company Sinovac Biotech for 50 million doses of CoronaVac, said in a statement late Wednesday, Dec. 2, 2020, that the first shipment of the inactivated vaccine will arrive in Turkey after Dec. 11. (AP Photo/Emrah Gurel, file)
December 03, 2020 - 2:57 am
ISTANBUL (AP) — Turkey’s health minister has announced a vaccination plan starting with an experimental “inactivated vaccine” later this month to combat the COVID-19 pandemic amid a surge in infections and deaths. Fahrettin Koca had previously announced an agreement with Chinese biopharmaceutical...
Read More
In this Monday, Nov. 9, 2020 photo, the company sign of BioNtech stands in front of the companies headquarters in Mainz, Germany. Pfizer and BioNTech say they've won permission Wednesday, Dec. 2, 2020, for emergency use of their COVID-19 vaccine in Britain, the world’s first coronavirus shot that’s backed by rigorous science -- and a major step toward eventually ending the pandemic. (Arne Dedert/dpa via AP)
December 02, 2020 - 1:21 pm
LONDON (AP) — British regulators have become the first to authorize the COVID-19 vaccine developed by American drugmaker Pfizer and Germany’s BioNTech for emergency use. Because trials of the vaccine have shown it has 95% efficacy, there is acute interest in how the U.K. plans to implement...
Read More
Russian President Vladimir Putin attends a meeting via video conference at the Novo-Ogaryovo residence outside Moscow, Russia, Wednesday, Dec. 2, 2020. Russian President Vladimir Putin announced start of large-scale vaccination of medics and teachers against COVID next week. Speaking during an online meeting dedicated to inauguration of new hospitals for coronavirus patients built by Russian Defense Ministry, Putin said Russia has enough capacity to start "large-scale" vaccination of teachers and doctors. (Alexei Nikolsky, Sputnik, Kremlin Pool Photo via AP)
December 02, 2020 - 11:52 am
MOSCOW (AP) — Russian President Vladimir Putin on Wednesday ordered the start of a “large-scale” COVID-19 vaccination by late next week, with doctors and teachers to be the first in line to receive the Sputnik V shots, which have yet to complete advanced studies needed to ensure its effectiveness...
Read More
FILE - In this July 27, 2020, file photo, Nurse Kathe Olmstead, right, gives volunteer Melissa Harting, of Harpersville, N.Y., an injection as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Hans Pennink, File)
December 02, 2020 - 12:52 am
NEW YORK (AP) — Health care workers and nursing home residents should be at the front of the line when the first coronavirus vaccine shots become available, an influential government advisory panel said Tuesday. The panel voted 13-1 to recommend those groups get priority in the first days of any...
Read More
FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)
December 01, 2020 - 12:47 pm
BERLIN (AP) — The European Union drug agency said Tuesday it may need four more weeks to approve its first coronavirus vaccine, even as authorities in the United States and Britain continue to aim for a green light before Christmas. The European Medicines Agency plans to convene a meeting by Dec...
Read More
FILE - In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna Inc. says it will ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection. (AP Photo/Hans Pennink, File)
KNSS News
November 30, 2020 - 8:00 am
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must...
Read More
FILE - In this file photo dated Wednesday, Sept. 2, 2020, University of Miami Miller School of Medicine lab technician processes blood samples from volunteers taking part in testing the NIH funded Moderna COVID-19 vaccine in Miami, USA. Britain said Sunday Nov. 29, 2020, it has secured 2 million more doses of a promising coronavirus vaccine developed by US firm Moderna, as the country aims to launch an inoculation program within days. (AP Photo/Taimy Alvarez, FILE)
November 29, 2020 - 12:25 pm
LONDON (AP) — Britain said Sunday it has secured 2 million more doses of a promising coronavirus vaccine as it gears up to launch within days the country's most ambitious inoculation program in decades. The U.K. has had Europe’s deadliest coronavirus outbreak, with more than 58,000 confirmed virus-...
Read More
FILE - In this Nov. 18, 2020, file photo, Arizona Gov. Doug Ducey puts his face mask on after addressing the media on COVID-19 during a news conference in Phoenix. Ducey has funneled nearly $400 million of federal coronavirus relief funds to state agencies to help pay for operations, allowing them to return some of their original budget allocations to the state treasury. (Michael Chow/The Arizona Republic via AP, File)
November 28, 2020 - 4:11 pm
PHOENIX — University of Arizona researchers say the current surge in the coronavirus outbreak will present the state with a hospital crisis that could become a disaster unless the state takes steps such as ordering a three-week stay-home shutdown and implementing a statewide mask mandate. Members...
Read More
James Teague, president of AstraZeneca's in Thailand attends a signing ceremony at Government House in Bangkok, Thailand Friday, Nov. 27, 2020. Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. (Chalinee Thirasupa/Pool Photo via AP)
November 27, 2020 - 5:32 am
BANGKOK (AP) — Thailand on Friday signed a deal to procure 26 million doses of the trial coronavirus vaccine developed by pharmaceutical firm AstraZeneca in collaboration with Oxford University. It is expected to be delivered in mid-2021. The doses would cover 13 million people in a population of...
Read More
This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. Pharmaceutical company AstraZeneca said Monday Nov. 23, 2020, that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. (University of Oxford/John Cairns via AP)
November 26, 2020 - 6:23 pm
LONDON (AP) — The British government said Friday it has formally asked the country’s medicines regulator to assess whether a coronavirus vaccine developed by AstraZeneca and Oxford University should be authorized for use. The step comes amid questions about preliminary results from trials of the...
Read More

Pages